Brain cancer survival improved following FDA approval of bevacizumab, study finds
A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease ...
Aug 19, 2013
0
0